Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Konstantinos Soureas
Observed name:
Soureas, Konstantinos
Institutions:
National and Kapodistrian University of Athens,
Panagiotis & Aglaia Kyriakou Children's Hospital
Observed institutions:
Vrije Universiteit Brussel,
National and Kapodistrian University of Athens,
Panagiotis & Aglaia Kyriakou Children's Hospital
ORCID:
0000-0002-4644-5625
Observed ORCID:
0000-0002-4644-5625
OpenAlex ID:
A5036418568
Exploring the methyl-verse: Dynamic interplay of epigenome and m6A epitranscriptome
2024
·
Katerina-Marina Pilala
, Konstantina Panoutsopoulou
, et al.
·
Molecular Therapy
·
48
Cancer quiescence: non-coding RNAs in the spotlight
2023
·
Konstantinos Soureas
, Maria-Alexandra Papadimitriou
, et al.
·
Trends in Molecular Medicine
·
28
miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma
2023
·
Maria-Alexandra Papadimitriou
, Konstantinos Soureas
, et al.
·
Journal of Translational Medicine
·
16
PDF
Deregulated Expression of IL-37 in Patients with Bladder Urothelial Cancer: The Diagnostic Potential of the IL-37e Isoform
2023
·
Maria Papasavva
, Styliana Amvrosiou
, et al.
·
International Journal of Molecular Sciences
·
12
PDF
Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome
2025
·
Konstantinos Soureas
, Panagiotis Malandrakis
, et al.
·
Blood Cancer Journal
·
10
Small RNA ‐seq and clinical evaluation of tRNA ‐derived fragments in multiple myeloma: Loss of mitochondrial i‐tRFHisGTG results in patients' poor treatment outcome
2024
·
Konstantinos Soureas
, Maria‐Alexandra Papadimitriou
, et al.
·
British Journal of Haematology
·
8
Loss of METTL3 m6A methyltransferase results in short‐term progression and poor treatment outcome of bladder cancer patients
2025
·
Katerina‐Marina Pilala
, Stella Koroneou
, et al.
·
International Journal of Cancer
·
3
PDF
Identification of Oncogene-Induced Senescence-Associated MicroRNAs
2025
·
Spyros Foutadakis
, Konstantinos Soureas
, et al.
·
Methods in molecular biology
·
1
Loss of Mir-221/222 Cluster Expression Results in Short-Term Disease Progression and Poor Post-Treatment Outcome in Multiple Myeloma
2023
·
Konstantinos Soureas
, Christos Minopoulos
, et al.
·
Blood
·
1
PDF
Liquid biopsy miRNA risk score in bladder cancer: Translational insights from patient-derived xenografts to prognostic stratification
2026
·
Maria-Alexandra Papadimitriou
, Katerina-Marina Pilala
, et al.
·
European Journal of Cancer
Targeting Collagens and LOX Through Plant-Derived MicroRNAs (XenomiRs)
2026
·
Paraskevi Ioannou
, Sylvia Mangani
, et al.
·
Methods in molecular biology
Delving into tRNA-derived small RNAs in multiple myeloma: elevated 3′U-tRFSerTGA leads to poor disease prognosis
2026
·
Konstantinos Soureas
, Panagiotis Malandrakis
, et al.
·
British Journal of Cancer
PDF
Abstract 3337: Unveiling m6A epitranscriptome-related genomic variations in bladder cancer: predictive biomarkers for disease progression and treatment outcome towards tailored therapeutics
2025
·
Andreas Scorilas
, Katerina-Marina Pilala
, et al.
·
Cancer Research
P-401 MiRNA-seq and clinical validation of miR-221/222 cluster in multiple myeloma
2023
·
Christos Minopoulos
, Konstantinos Soureas
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
P-412 Loss of 3'U-tRFHisGTG in predicting poor survival and treatment outcome in multiple myeloma
2023
·
Konstantinos Soureas
, Maria-Alexandra Papadimitriou
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
28
Citation count:
127
H-index:
6
I10-index:
5
Year
Topic
Type